190
Views
5
CrossRef citations to date
0
Altmetric
Review

Sources of variability in quantifying circulating thymosin beta-4: literature review and recommendations

ORCID Icon, , , , , ORCID Icon & ORCID Icon show all
Pages 141-147 | Received 03 Jan 2018, Accepted 01 Mar 2018, Published online: 12 Mar 2018

References

  • Sosne G, Qiu P, Goldstein AL, et al. Biological activities of thymosin beta4 defined by active sites in short peptide sequences. Faseb J. 2010;24:2144–2151.
  • Goldstein AL, Hannappel E, Sosne G, et al. Thymosin β4: a multi-functional regenerative peptide. Basic properties and clinical applications. Expert Opin Biol Ther. 2012;12:37–51.
  • Goldstein AL, Kleinman HK. Advances in the basic and clinical applications of thymosin β4. Expert Opin Biol Ther. 2015;15(Suppl 1):S139–45.
  • Choudry FA, Yeo C, Mozid A, et al. Increases in plasma Tβ4 after intracardiac cell therapy in chronic ischemic heart failure is associated with symptomatic improvement. Regen Med. 2015;10:403–410.
  • Drum CL, Tan WKY, Chan S, et al. Thymosin beta-4 Is elevated in women with heart failure with preserved ejection fraction. J Am Heart Assoc. 2017;6:e005586.
  • Yeşilay AB, Karakurt O, Akdemir R, et al. Thymosin beta4 levels after successful primary percutaneous coronary intervention for acute myocardial infarction. Arch Turk Soc Cardiol. 2011;39:654–660.
  • Song R, Choi HM, Yang H-I, et al. Association between serum thymosin β4 levels of rheumatoid arthritis patients and disease activity and response to therapy. Clin Rheumatol. 2012;31:1253–1258.
  • Belsky JB, Morris DC, Bouchebl R, et al. Plasma levels of F-actin and F:G-actin ratio as potential new biomarkers in patients with septic shock. Biomarkers. 2016;21:180–185.
  • Holland RL. What makes a good biomarker? Adv Precis Med. 2016;1:4–11.
  • Dong Q, Han T, Wang L, et al. The significance of serum thymosin β4 Levels in patients with non-alcoholic fatty liver disease. Tianjin Med J. 2013;41:97–100.
  • Weller FE, Shah U, Cummings GD, et al. Serum levels of immunoreactive thymosin α1 and thymosin β4 in large cohorts of healthy adults. Thymus. 1992;19:45–52.
  • Weller FE, Mutchnick MG, Goldstein AL, et al. Enzyme immunoassay measurement of thymosin β4 in human serum. J Biol Response Mod. 1988;7:91–96.
  • Naylor PH, Friedman-Kien A, Hersh E, et al. Thymosin α1 and thymosin β4 in serum: comparison of normal, cord, homosexual and AIDS serum. Int J Immunopharmacol. 1986;8:667–676.
  • Suh BY, Naylor PH, Goldstein AL, et al. Modulation of thymosin beta 4 by estrogen. Am J Obstet Gynecol. 1985;151:544–549.
  • Hannappel E, van Kampen M. Determination of thymosin beta 4 in human blood cells and serum. J Chromatogr. 1987;397:279–285.
  • Tang Y-Q, Yeaman MR, Selsted ME. Antimicrobial peptides from human platelets. Infect Immun. 2002;70:6524–6533.
  • Huff T, Otto AM, Müller CSG, et al. Thymosin beta4 is released from human blood platelets and attached by factor XIIIa (transglutaminase) to fibrin and collagen. Faseb J. 2002;16:691–696.
  • Makogonenko E, Goldstein AL, Bishop PD, et al. Factor XIIIa incorporates thymosin beta4 preferentially into the fibrin(ogen) alphaC-domains. Biochemistry. 2004;43:10748–10756.
  • Hannappel E. Thymosin beta4 and its posttranslational modifications. Ann N Y Acad Sci. 2010;1194:27–35.
  • Cabras T, Iavarone F, Martelli C, et al. High-resolution mass spectrometry for thymosins detection and characterization. Expert Opin Biol Ther. 2015;15(Suppl 1):S191–201.
  • Plavina T, Hincapie M, Wakshull E, et al. Increased plasma concentrations of cytoskeletal and Ca2+-binding proteins and their peptides in psoriasis patients. Clin Chem. 2008;54:1805–1814.
  • Zheng X, Wu S-L, Hincapie M, et al. Study of the human plasma proteome of rheumatoid arthritis. J Chromatogr A. 2009;1216:3538–3545.
  • Hemoconcentration. [Cited 5 Mar 2018]. Available from: http://www.phlebotomy.com/pt-stat/stat0508.html.
  • Söderström AC, Nybo M, Nielsen C, et al. The effect of centrifugation speed and time on pre-analytical platelet activation. Clin Chem Lab Med. 2016;54:1913–1920.
  • Coupes BM, Williams S, Roberts IS, et al. Plasma transforming growth factor β1 and platelet activation: implications for studies in transplant recipients. Nephrol Dial Transpl. 2001;16:361–367.
  • Rasi V. β-Thromboglobulin in plasma; false high values caused by platelet enrichment of the top layer of plasma during centrifugation. Thromb Res. 1979;15:543–552.
  • Maurer-Spurej E, Pfeiler G, Maurer N, et al. Room temperature activates human blood platelets. Lab Invest. 2001;81:581–592.
  • Knop J, App C, Hannappel E. Antibodies in research of thymosin β4: investigation of cross-reactivity and influence of fixatives. Ann N Y Acad Sci. 2012;1270:105–111.
  • Hannappel E. β-Thymosins. Ann N Y Acad Sci. 2007;1112:21–37.
  • Hannappel E. One-step procedure for the determination of thymosin beta 4 in small tissue samples and its separation from other thymosin beta 4-like peptides by high-pressure liquid chromatography. Anal Biochem. 1986;156:390–396.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.